Moderna Confirms COVID Vaccine Safety for Kids Below 6

Moderna Confirms COVID Vaccine Safety for Kids Below 6

  • Moderna announced the conclusion of Phase 2 and 3 clinical trials for its COVID vaccine in children below 6, on Thursday
  • The company aims to have the vaccine available for children under the age of five from June this year
  • The vaccine manufacturer’s COVID 19 jab has been approved only for adults 18 and older, although there are concerns of myocarditis in people under 30
Moderna announced on Wednesday that its vaccine works in children below the age of 6, a development that could allow the vaccine to be used in babies and toddlers if regulators agree.


The company disclosed that it is set to ask regulators in the U.S. and Europe for authorization of two shots of vaccine for kids below 6, in the coming weeks.

This comes as the vaccine manufacturer is still seeking permission for the vaccine to be used in older children and teens.

This announcement will come as great news to parents who have been seeking protection for their children in the face of the pandemic.

At the moment the United State’s 18 million kids below 5 are the only section of the population that are ineligible for vaccination.

Modern stated that its trials revealed that u-6 kids develop high levels of virus-fighting antibodies from shots containing a quarter of the dose administered to adults.

Read also: England Rolls Out 4th COVID Jab For Virus Protection

Once Moderna submits its full data, the U.S. Food and Drug Administration will have to determine if the vaccine is suitable for administering.

At the moment, Modera’s jabs are approved for people above 18, even though there have been cases of myocarditis forming in recipients under the age of 30.

Follow on social media handles: FacebookInstagram, and Twitter for trending news, entertainment news, and hot gist.

Show More

Related Articles

Back to top button